ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 135 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 2.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $5,240,000 | +364.1% | 445,200 | +438.3% | 0.01% | +150.0% |
| Q1 2019 | $1,129,000 | +72.1% | 82,700 | +29.2% | 0.00% | +33.3% |
| Q4 2018 | $656,000 | +110.9% | 64,000 | +224.9% | 0.00% | +200.0% |
| Q2 2018 | $311,000 | -95.6% | 19,700 | -96.5% | 0.00% | -96.4% |
| Q1 2018 | $7,085,000 | -43.1% | 557,909 | -48.7% | 0.03% | -42.9% |
| Q4 2017 | $12,448,000 | +2.4% | 1,087,209 | +9.6% | 0.05% | -5.8% |
| Q3 2017 | $12,153,000 | +220.8% | 992,083 | +199.9% | 0.05% | +205.9% |
| Q2 2017 | $3,788,000 | -46.9% | 330,830 | -3.6% | 0.02% | -46.9% |
| Q1 2017 | $7,138,000 | +28.6% | 343,193 | +28.7% | 0.03% | +23.1% |
| Q4 2016 | $5,549,000 | -35.3% | 266,758 | +1.9% | 0.03% | -31.6% |
| Q3 2016 | $8,576,000 | +19.8% | 261,690 | -8.7% | 0.04% | +18.8% |
| Q2 2016 | $7,157,000 | +15.4% | 286,620 | +13.2% | 0.03% | +14.3% |
| Q1 2016 | $6,200,000 | -27.0% | 253,179 | -1.6% | 0.03% | -24.3% |
| Q4 2015 | $8,498,000 | +6.1% | 257,269 | +5.2% | 0.04% | +12.1% |
| Q3 2015 | $8,010,000 | -20.2% | 244,509 | +29.1% | 0.03% | -17.5% |
| Q2 2015 | $10,034,000 | – | 189,435 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,130 | $37,365,000 | 8.14% |
| Foresite Capital Management II, LLC | 1,686,220 | $21,415,000 | 7.12% |
| Foresite Capital Management IV, LLC | 830,919 | $10,553,000 | 4.38% |
| SENZAR ASSET MANAGEMENT, LLC | 822,890 | $10,451,000 | 3.30% |
| Redmile Group, LLC | 6,505,766 | $82,623,000 | 3.19% |
| DAFNA Capital Management LLC | 396,013 | $5,029,000 | 2.45% |
| SECTORAL ASSET MANAGEMENT INC | 863,600 | $10,968,000 | 1.20% |
| Palo Alto Investors LP | 1,849,832 | $23,493,000 | 1.00% |
| Bellevue Group AG | 700,464 | $8,896,000 | 0.88% |
| Rock Springs Capital Management LP | 1,529,800 | $19,428,000 | 0.83% |